MUSC Catalyst News

Researchers are working to understand why neurons respond more strongly to drug cues than cues for natural rewards, like sugar.

If the traffic light hadn’t turned red when it did, a Greenville father known as a “gentle giant” wouldn’t be recovering from life-saving surgery.

An MUSC Hollings Cancer Center Phase II clinical trial will examine the safety and efficacy of a new combination of drugs for treating a rare form of lymphoma.

Employees, students and the public can now get the flu shot at on-campus satellite events and at MUSC Health Primary Care offices through December.

The LOWVELO College Cup is an opportunity for MUSC students, faculty and staff to show off their college’s dedication to funding lifesaving cancer research.

MUSC researchers use deep learning models to identify patients at risk of intentional self-harm based on unstructured patient clinical notes alone.

Spinal cord injury researchers continue to make progress in aging and quality of life research for people.

The Bonilha lab at MUSC is working to better understand the complexity of brain networks, and along the way to help people with aphasia and epilepsy.

In-depth study by economist documents MUSC’s increasing impact across South Carolina in terms of both money and jobs.

Latest update from MUSC COVID-19 Epidemiology Intelligence Project is encouraging. But project’s leader says: Brace yourself.